Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis
- PMID: 15466196
- DOI: 10.1158/0008-5472.CAN-04-1647
Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis
Abstract
Nuclear factor-kappaB (NF-kappaB) plays a critical role during fetal liver development and hepatic oncogenesis. Here, we have assessed whether NF-kappaB activity is required for murine hepatocellular carcinoma cell survival. We show that adenoviral-mediated inhibition of inhibitor of NF-kappaB kinase-beta (IKK-2) activity in hepatocellular carcinomas derived from transforming growth factor (TGF)-alpha/c-myc bitransgenic mice leads to inhibition of NF-kappaB and promotes tumor necrosis factor (TNF)-alpha-mediated cell death of malignant hepatocytes but not the surrounding peritumorous tissue. Induction of apoptosis is accompanied by inhibition of Bcl-X(L) and XIAP, two pro-survival NF-kappaB target genes. In addition, we have identified the alpha-fetoprotein (AFP) as a novel downstream target of NF-kappaB. We show that repression of IKK-2 activity in hepatocellular carcinomas promotes down-regulation of AFP gene expression. Likewise, genetic disruption of the RelA subunit results in reduced AFP gene expression during embryonic liver development, at a time in which fetal hepatocytes are sensitized to TNF-alpha-mediated cell killing. In this regard, we show that AFP inhibits TNF-alpha-induced cell death of murine hepatocellular carcinomas through association with TNF-alpha and inhibition of TNFRI signaling. Thus, NF-kappaB-mediated regulation of AFP gene expression during liver tumor formation and embryonic development of the liver constitutes a potential novel mechanism used by malignant and fetal hepatocytes to evade immune surveillance.
Similar articles
-
Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.Mol Cancer Res. 2005 Jul;3(7):403-12. doi: 10.1158/1541-7786.MCR-04-0186. Mol Cancer Res. 2005. PMID: 16046551
-
Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.Oncogene. 2003 Jan 23;22(3):412-25. doi: 10.1038/sj.onc.1206132. Oncogene. 2003. PMID: 12545162
-
Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.Hepatology. 2001 Jul;34(1):32-41. doi: 10.1053/jhep.2001.25270. Hepatology. 2001. PMID: 11431731
-
Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond.Endocr Rev. 2007 Jun;28(4):365-86. doi: 10.1210/er.2006-0031. Epub 2007 Apr 12. Endocr Rev. 2007. PMID: 17431229 Review.
-
Tumor necrosis factor signaling in hepatocyte apoptosis.J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S43-4. doi: 10.1111/j.1440-1746.2006.04645.x. J Gastroenterol Hepatol. 2007. PMID: 17567463 Review.
Cited by
-
Beta2-GPI: a novel factor in the development of hepatocellular carcinoma.J Cancer Res Clin Oncol. 2010 Nov;136(11):1671-80. doi: 10.1007/s00432-010-0825-8. Epub 2010 Mar 4. J Cancer Res Clin Oncol. 2010. PMID: 20204408
-
Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).Mar Drugs. 2015 Nov 13;13(11):6884-909. doi: 10.3390/md13116884. Mar Drugs. 2015. PMID: 26580630 Free PMC article. Review.
-
alpha-Fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes.Br J Pharmacol. 2009 Nov;158(5):1236-47. doi: 10.1111/j.1476-5381.2009.00401.x. Epub 2009 Sep 28. Br J Pharmacol. 2009. PMID: 19785658 Free PMC article.
-
Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.Hepatology. 2012 Jan;55(1):121-31. doi: 10.1002/hep.24653. Epub 2011 Dec 6. Hepatology. 2012. PMID: 21898503 Free PMC article.
-
Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.Gastroenterology. 2006 Jan;130(1):104-19. doi: 10.1053/j.gastro.2005.10.012. Gastroenterology. 2006. PMID: 16401474 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials